SavedAdd your journal

Journals / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 4

Comparison of the Treatment Cost of COVID-19 andNon-COVID-19 Patients in the Intensive Care Unit

Gülsüm KAVALCI
Pages
393–396
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Spearman’s correlation coefficient was used to determine thecorrelation between treatment cost and variables.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to compare the cost of treating coronavirus disease 2019 (COVID-19) and non-COVID-19patients in our intensive care unit (ICU).
📊
Key Findings & Data:Materials and Methods: Patient data such as age, gender, comorbidities, radiological findings, treatments received, lengthof stay in the ICU, polymerase chain reaction (PCR) test result, and invoice issued at the time of discharge were recorded.The patients were divided into two groups, including patients being treated for COVID-19 (Group 1) and those being treatedfor other diseases (non-COVID-19) (Group 2).
💡
Conclusion & Impact:Spearman’s correlation coefficient was used to determine thecorrelation between treatment cost and variables.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: This study aimed to compare the cost of treating coronavirus disease 2019 (COVID-19) and non-COVID-19patients in our intensive care unit (ICU). Materials and Methods: Patient data such as age, gender, comorbidities, radiological findings, treatments received, lengthof stay in the ICU, polymerase chain reaction (PCR) test result, and invoice issued at the time of discharge were recorded.The patients were divided into two groups, including patients being treated for COVID-19 (Group 1) and those being treatedfor other diseases (non-COVID-19) (Group 2). The chi-square test (χ2) was used to compare categorical variables. Continuousvariables were compared using the Mann–Whitney U test. Spearman’s correlation coefficient was used to determine thecorrelation between treatment cost and variables. A p-value of

🔖

Cite This Article

KAVALCI, G. (2022). Comparison of the Treatment Cost of COVID-19 andNon-COVID-19 Patients in the Intensive Care Unit. Erciyes Medical Journal, Cilt: 43 - Sayı: 4, 393–396. https://ajindex.com/articles/650109

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Güner R, Hasanoğlu I, Aktaş F. COVID-19: Prevention and control measures in community. Turk J Med Sci 2020
  2. 50(SI-1): 571–7 2. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol 2020
  3. 5(7): 802–10. 3. Akbaş T, Eşbah AÜ. Intensive Care Practice during COVID-19 Pandemia in Duzce University. Konuralp Tıp Dergisi 2020
  4. 12(S1): 369–71. 4. Djankov S, Panizza U. COVID-19 in Developing Economies. A VoxEU.org Book. 2020. Available from: URL: https://voxeu.org/content/covid-19-developing-economies. 5. Yamin M. Counting the cost of COVID-19. Int J info Tecnol 2020
  5. 311–7. 6. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 2020
  6. 395(10227): 912–20. 7. Bartsch SM, Ferguson MC, McKinnell JA, O’Shea KJ, Wedlock PT, Siegmund SS, et al. The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States. Health Aff (Millwood) 2020
  7. 39(6): 927–35. 8. Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al
  8. COVID-19 Lombardy ICU Network. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med 2020
  9. 180(10): 1345– 55. 9. Barrasa H, Rello J, Tejada S, Martín A, Balziskueta G, Vinuesa C, et al
  10. Alava COVID-19 Study Investigators. SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria. Anaesth Crit Care Pain Med 2020
  11. 39(5): 553–61. 10. Mitra AR, Fergusson NA, Lloyd-Smith E, Wormsbecker A, Foster D, Karpov A, et al. Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series. CMAJ 2020
  12. 192(26): E694–701. 11. Kokoszka-Bargieł I, Cyprys P, Rutkowska K, Madowicz J, Knapik P. Intensive Care Unit Admissions During the First 3 Months of the COVID-19 Pandemic in Poland: A Single-Center, Cross-Sectional Study. Med Sci Monit 2020
  13. e926974. 12. Temel Ş, Gündoğan K, Ülger B, Arican H, Bulut K, Sari A, et al. Characteristics and Outcomes of the Patients Infected with SARS-CoV-2 Admitted to Intensive Care Units: Erciyes University COVID-19 Center Experience. Erciyes Med J 2020
  14. 42(4): 436–40. 13. Armstrong RA, Kane AD, Cook TM. Outcomes from intensive care in patients with COVID-19: a systematic review and meta-ana